Hyperlipoproteinemia causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
| Line 19: | Line 19: | ||
*[[Aerobic exercise]] | *[[Aerobic exercise]] | ||
*[[Alcoholism]] | *[[Alcoholism]] | ||
*[[Androgens]] | |||
*[[Anorexia nervosa]] | *[[Anorexia nervosa]] | ||
*[[apolipoprotein E|Apolipoprotein E deficiency]] | |||
*[[Beta blockers]]<ref name="pmid7992988">{{cite journal| author=Kasiske BL, Ma JZ, Kalil RS, Louis TA| title=Effects of antihypertensive therapy on serum lipids. | journal=Ann Intern Med | year= 1995 | volume= 122 | issue= 2 | pages= 133-41 | pmid=7992988 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7992988 }} </ref> | |||
*[[Binge eating disorder]] | |||
*[[Cannabis]] | *[[Cannabis]] | ||
*[[Chronic liver disease]] | |||
*[[Chronic renal failure]] | *[[Chronic renal failure]] | ||
*[[Diabetes mellitus]] | *[[Corticosteroids]]<ref name="pmid12922956">{{cite journal| author=Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE et al.| title=Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. | journal=Ann Rheum Dis | year= 2003 | volume= 62 | issue= 9 | pages= 842-5 | pmid=12922956 | doi= | pmc=PMC1754645 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12922956 }} </ref> | ||
*[[Diabetes mellitus type 2]] | |||
*[[Diabetic nephropathy]] | |||
*[[Doxazosin]] | *[[Doxazosin]] | ||
*[[Estrogen]] | *[[Estrogen]] | ||
*[[Estrogens]] | |||
*[[Weight loss|Excessive weight loss]] | *[[Weight loss|Excessive weight loss]] | ||
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref><ref name="pmid1534286">{{cite journal| author=Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH et al.| title=Familial lipoprotein disorders in patients with premature coronary artery disease. | journal=Circulation | year= 1992 | volume= 85 | issue= 6 | pages= 2025-33 | pmid=1534286 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1534286 }} </ref> | |||
*[[Fibrates]] | *[[Fibrates]] | ||
*[[Hepatitis]] | |||
{{col-break|width=33%}} | |||
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi = | PMID = 15259529 }}</ref> | |||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Liver cirrhosis]] | *[[Liver cirrhosis]] | ||
*[[Lovaza]] | *[[Lovaza]] | ||
*[[Magnesium]] | *[[Magnesium]] | ||
*[[Metabolic syndrome]] | |||
*[[Alcohol and cardiovascular disease#Possible Mechanisms of Benefits|Moderate alcohol consumption]] | *[[Alcohol and cardiovascular disease#Possible Mechanisms of Benefits|Moderate alcohol consumption]] | ||
*[[Nephrotic syndrome]] | |||
*[[Niacin]] | *[[Niacin]] | ||
*[[Obesity]] | |||
*[[Omega-3 fatty acid]] | *[[Omega-3 fatty acid]] | ||
*[[Combined oral contraceptive pill|Oral contraceptives]] | *[[Combined oral contraceptive pill|Oral contraceptives]] | ||
*[[Prazosin]] | *[[Prazosin]] | ||
*[[Pregnancy]] | *[[Pregnancy]] | ||
*[[Progestagens]] | |||
*[[Smoking cessation]] | *[[Smoking cessation]] | ||
*[[Statins]] | *[[Statins]] | ||
*[[ | *[[Thiazide diuretics]] | ||
*[[Unsaturated fat]] | *[[Unsaturated fat]] | ||
{{col-end}} | {{col-end}} | ||
Revision as of 20:55, 13 November 2013
|
Hyperlipoproteinemia Microchapters |
|
ACC/AHA Guideline Recommendations |
|
Intensity of statin therapy in primary and secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes based on Major Lipoprotein Detected in Blood Laboratory Test
Combined List of Causes in Alphabetical Order
References
- ↑ Kasiske BL, Ma JZ, Kalil RS, Louis TA (1995). "Effects of antihypertensive therapy on serum lipids". Ann Intern Med. 122 (2): 133–41. PMID 7992988.
- ↑ Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE; et al. (2003). "Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis". Ann Rheum Dis. 62 (9): 842–5. PMC 1754645. PMID 12922956.
- ↑ Durrington, P. (2003). "Dyslipidaemia". Lancet. 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Unknown parameter
|month=ignored (help) - ↑ Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH; et al. (1992). "Familial lipoprotein disorders in patients with premature coronary artery disease". Circulation. 85 (6): 2025–33. PMID 1534286.
- ↑ Covington, MB. (2004). "Omega-3 fatty acids". Am Fam Physician. 70 (1): 133–40. PMID 15259529. Unknown parameter
|month=ignored (help)